Search

Skip to main content Net Benefit of HCC screening We have promoted the concept of net benefit for HCC screening, which involves balancing early detection with potential screening-related harms. We have characterized the clinical benefits of screening, including improved early tumor detection and asso…

Contact the Rothermel Lab.

Skip to main content Resilience and Suicidal Ideation Research Because depression often begins early in life, our goal is to proactively study the disease in young people to ultimately prevent or minimize its impact population-wide. To further this goal of reducing adolescent suicidality, our team ha…

Skip to main content Depression Research Our Clinical Trials Depression is a major health challenge affecting more than 300 million people globally. Research suggests that 1 in 6 people will experience depression in their lifetime with an 18% increase over the past decade. Of the more than 17 million…

Rothermel Lab publications.

Learn about the Sun Lab's resources.

The Drapkin Lab investigates the molecular drivers of oncogenesis, metastasis, and chemoresistance in small cell lung cancer (SCLC) to discover new therapeutic targets. 

Sun Lab news.

Contact the Sun Lab.

Summary of previous research according to topics